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Abstract
Blood transfusion-free complex congenital cardiac surgery in a neonate remains a challenge for multidisciplinary cardiac teams. At our
institution, a 3.5 kg neonate, born to a family of Jehovah’s Witnesses and postnatally diagnosed with dextro-transposition of the great
arteries (d-TGA) and a small muscular ventricular septal defect, underwent a successful arterial switch operation without blood or plate-
let transfusion. Key points that contributed to success were optimal preoperative haematopoetic conditioning using erythropoietin and
iron, a miniaturized cardiopulmonary bypass circuit including a low prime volume oxygenator and crystalloid cardioplegia, and a well-
coordinated multidisciplinary team. We report an overview of the literature regarding blood transfusion-free complex congenital
cardiac surgery.
Keywords: Congenital cardiac surgery • Arterial switch operation • Jehovah’s Witness • Blood transfusion-free
INTRODUCTION
The evolution of blood transfusion-sparing medicine is not only
being driven by medical and economic factors, but also by
groups with specific religious beliefs, such as Jehovah’s
Witnesses. In addition to the inevitable intraoperative fall of
haemoglobin due to blood loss, the haemodilution due to the
priming volume needed to fill the cardiopulmonary bypass
(CPB) circuit has a particular impact on the intraoperative drop
in haemoglobin. The high priming volume of the CPB circuit is
the most important factor leading to haemodilution, particularly
in neonates. We describe the joint effort of surgeons, perfusio-
nists, anaesthetists and intensive-care doctors resulting in a
modified CPB circuit with the goal of minimizing intraoperative
haemodilution, thus allowing blood transfusion-free neonatal
repair of congenital heart defects.
CASE REPORT
A male newborn was transferred to our institution after a post-
natal diagnosis of dextro-transposition of the great arteries
(d-TGA) with a small muscular ventricular septal defect (VSD) of
3–3.5 mm. After initial treatment, the operation was planned. In
accordance with the parental wishes to avoid a blood transfusion
if at all possible, the patient’s intrinsic red cell production was
optimized for surgery with iron (2.1 mg/kg/day) and erythropoi-
etin (150 IU/kg every third day) supplementation starting 7 days
before the operation (haemoglobin level before erythropoietin
treatment 148 g/l). The parents were informed that all efforts
would be made to avoid blood transfusion, but that in the
event of a life-threatening situation, the child would be given
blood. Surgery was performed on the ninth day of life at a
body weight of 3.53 kg, with a haemoglobin level of 157 g/l.
Near-infrared spectroscopy (NIRS) was used intra- and post-
operatively to measure cerebral oxygenation. A median sternot-
omy was performed, followed by routine cannulation for CPB
and cooling to a body temperature of 28°C. The CPB circuit
(including the arterial line filter) used for this patient was opti-
mized to reduce the total priming volume to 95 ml (Multibic
Hämofiltrationslösung, Fresenius Medical Care, Oberdorf,
Switzerland). The length and diameter of the non-heparin
bonded tubing of the CPB circuit were reduced, and the oxygen-
ator and CPB machine were placed as close as possible to the
operating table. All the tubing was 3/16-inch in internal diam-
eter, except for the arterial line, which was 1/8-inch in diameter.
Cardioplegic arrest of the heart was achieved with an aortic root
injection of 20 ml of crystalloid Kirsch cardioplegia solution
(Mg-Aspartat Procain, Köhler-Chemie, Alsbach, Germany) fol-
lowed by 20 ml of hydroxyl ethyl starch (Fresenius AG, Bad
Homburg, Germany). d-TGA was corrected using the standard
arterial switch procedure, and the VSD was closed using a direct
suture. Antifibrinolysis was achieved by infusing tranexamic acid.
At the end of the CPB, all the remaining blood was returned to
the patient with the Cell-Saver system (100 ml washed blood).
During CPB and postoperatively in the intensive care unit (ICU),
blood sampling was reduced to a minimum. The lowest intra-
operative haemoglobin was 72 g/l, the lowest haematocrit was
22.5%, the NIRS remained between 50 and 70%, and the lactate
was 1.6–3.9 mmol/l. There was no evidence of inadequate
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systemic oxygen delivery either during the operation or during
the postoperative period despite a postoperative haemoglobin
value of 72 g/l on return to the ICU. Postoperative management
involved the use of colloid as volume replacement (albumin 4%)
to optimize intravascular colloid osmotic pressure and avoid
blood transfusion; milrinone, adrenaline and noradrenaline infu-
sion were used to optimize the cardiac output. Preoperative
treatment using iron and erythropoietin was continued post-
operatively for another 4 weeks. No red blood cell or platelet
transfusion was given during the patient’s treatment. The haemo-
globin and haematocrit values were as depicted graphically
in Fig. 1.
DISCUSSION
While there is a consensus that innovations that help reduce the
use of blood and blood products be pursued in order to reduce
the risks associated with homologous blood, ensuring the safety
of the procedure with regard to early as well as late outcome is
of paramount importance. While it is true that liberal post-
operative transfusion protocols have shown no advantages com-
pared with a more restrictive transfusion protocol and that
blood transfusions have been associated with higher complica-
tion rates [1], the limits to which blood-sparing infant congenital
cardiac surgery can be pursued are ill-defined. There are some
reports which show that infants undergoing cardiac surgery with
a haematocrit of 25% and greater have better perioperative and
developmental outcomes [2, 3]. The religious beliefs of Jehovah’s
Witnesses requiring them to avoid transfusion of any component
of blood, pose a challenge to safe neonatal cardiac surgery
using CPB.
Using the case of a neonatal blood and blood product-free
arterial switch operation in a neonate born to Jehovah’s Witness
parents, we intend to highlight the strategic and operational
measures that can be adopted to reduce the perioperative need
for blood.
First, optimizing the patient for surgery is of utmost import-
ance. Preoperative anaemia is an additive risk factor for adverse
outcome after cardiac surgery, even when subsequently cor-
rected with red blood cell transfusion. Consequently, the peri-
operative use of iron and erythropoiesis-stimulating agents has
been recommended. It has been reported that even the admin-
istration of a single dose of erythropoietin 7 days prior to
surgery has an effect by increasing the haematocrit levels [4].
Further, one of the key elements to avoid excessive haemodi-
lution is the reduction in the priming volume of the CPB circuit,
which should be aimed for regardless of religious beliefs.
Miniaturized CPB circuits using a priming volume ranging from
130 to 550 ml have previously been reported. The use of a CPB
circuit in this case with a priming volume of 95 ml is a significant
improvement compared with other reports.
While saving on blood, safe oxygen delivery to the tissues
during CPB needs to be ensured. Cerebral monitoring by NIRS
provides a good measure of the adequacy of the oxygen supply
to the tissues. To avoid poor outcome, intraoperative thresholds
for blood transfusion have been reported as a haematocrit <20%
on CBP, a brain oxygenation (measured by NIRS) <50%, a lactate
level >4 mmol/l and central venous oxygen saturation of <70% [5].
We believe that a low priming volume circuit and short-term
use of erythropoiten and iron may offer the possibility of blood
transfusion-free neonatal cardiac surgery, but a careful assess-
ment of each patient’s unique clinical situation and a well-
trained interdisciplinary team approach are mandatory. The
need to consent to a rescue blood transfusion in a life-
threatening scenario, as well as the unknowns about the risks to
neurodevelopmental outcomes have to be explained to parents.
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Figure 1: Course of haemoglobin (Hb) and haematocrit (Hct) levels; CPB:
cardiopulmonary bypass; POD: postoperative day.
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